Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma

Journal of the National Cancer Institute

Volumn 88, Issue 16, 1996, Pages 1110-1117

  Takebayashi, Yuji ^a   Akiyama, Shin Ichi ^a   Akiba, Suminori ^b   Yamada, Kazutaka ^b   Miyadera, Kazutaka ^a   Sumizawa, Tomoyuki ^a   Yamada, Yuji ^c   Murata, Fusayoshi ^b   Aikou, Takashi ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; MONOCLONAL ANTIBODY; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE PHOSPHORYLASE;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CARCINOMA; DISEASE COURSE; ENZYME ASSAY; LYMPH NODE METASTASIS; MICROVASCULATURE; PROGNOSIS;

EID: 0029790295     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.16.1110     Document Type: Article

References (42)

1. Iltzsch MH, el Kouni MH, Cha S. Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry 1985;24:6799-807.
2. Friedkin D, Roberts D. The enzymatic synthesis of nucleosides. J Biol Chem 1954;207:245-56.
3. Krenitsky TA, Koszalka GW, Tuttle JV. Purine nucleoside synthesis, an efficient method employing nucleoside phosphorylases. Biochemistry 1981;20:3615-21.
4. Zimmerman M, Seidenberg J. Deoxyribosyl transfer. J Biol Chem 1964;230:2618-21.
5. Gallo RC, Perry S, Breitman TR. The enzymatic mechanisms for deoxythymidine synthesis in human leukocytes. I. Substrate inhibition by thymine and activation by phosphate or arsenate. J Biol Chem 1967; 242:5059-68.
6. Krenitsky TA. Pentosyl transfer mechanisms of the mammalian nucleoside phosphorylases. J Biol Chem 1968;243:2871-5.
7. Desgranges C, Razaka G, Rabaud H, Bricaud H. Catabolism of thymidine in human blood platelets: purification and properties of thymidine phosphorylase. Biochim Biophys Acta 1981;654:211-8.
8. Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyuma S, Fukui K, et al. Angiogenic factor [letter]. Nature 1992;356:668.
9. Sumizawa T, Furukawa T, Haraguchi M, Yoshimura A, Takeyasu A, Ishizawa M, et al. Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. J Biochem (Tokyo) 1993; 114:9-14.
10. Haraguchi M, Miyadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K, et al. Angiogenic activity of enzymes [letter]. Nature 1994;368:198.
11. Ishikawa F, Miyazono K, Hellman U, Drexler M, Wernstedt C, Hagiwara K. et al. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989; 338:557-62.
12. Miyazono K, Okabe T, Urabe A, Takaku F, Heldin CH. Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem 1987;262:4098-103.
13. Miyazono K, Heldin CH. High-yield purification of platelet-derived endothelial cell growth factor: structural characterization and establishment of a specific antiserum. Biochemistry 1989;28:1704-10.
14. Miyadera K, Sumizawa T, Haraguchi M, Yoshida H, Konstanty W, Yamada Y, et al. Role of thymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res 1995;55:1687-90.
15. Pauly JL, Schuller MG, Zelcer AA, Kirss TA, Gore SS, Germain MJ. Identification and comparative analysis of thymidine phosphorylase in the plasma of healthy subjects and cancer patients. J Natl Cancer Inst 1977; 58:1587-90.
16. Pauly JL, Paolini NS, Ebarb RL, Germain MJ. Elevated thymidine phosphorylase activity in the plasma and ascitic fluids of tumor-bearing animals. Proc Soc Exp Biol Med 1978;157:262-7.
17. Yoshimura A, Kuwazuru Y, Furukawa T, Yoshida H, Yamada K, Akiyama S. Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochim Biophys Acta 1990;1034:107-13.
18. Takebayashi Y, Yamada K, Maruyama I, Fujii R, Akiyama S, Aikou T. The expression of thymidine phosphorylase and thrombomodulin in human colorectal carcinoma. Cancer Lett 1995;92:1-7.
19. Folkman J, Klagsburn M. Angiogenic factors. Science 1987;235:442-7.
20. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
21. Liotta LA, Kleinerman J, Saidel GM. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 1974;34:997-1004.
22. Srivastava A, Laidler P, Hughes LE, Woodcock J, Shedden EJ. Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study. Eur J Cancer Clin Oncol 1986;22:1205-9.
23. Srivastava A, Laidler P, Davies RP, Horgan K, Hughes LE. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. Am J Pathol 1988;133:419-23.
24. Herlyn M, Clark WH, Rodeck U, Mancianti ML, Jambrosic J, Koprowski H. Biology of tumor progression in human melanocytes. Lab Invest 1987;56:461-74.
25. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM. Expression of vascular endothelial growth factor and its receptor. KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995;55:3964-8.
26. Jass JR, Sobin LH. World Health Organization international histological classification of tumors: histological typing of intestinal tumors. 2nd ed. New York: Springer-Verlag, 1989.
27. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954;139:846-52.
28. Hsu SM, Raine L, Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 1981;75:734-8.
29. Fox SB, Moghaddam A, Westwood M, Turley H, Bicknell R, Gatter KC, et al. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J Pathol 1995;176:183-90.
30. Takebayashi Y, Yamada K, Miyadera K, Kinoshita F, Aoki D, Okumura H, et al. The activity and expression of thymidine phosphorylase in human solid tumors. Eur J Cancer. In press.
31. Zar JH. Biostatistical analysis. 3d edition, New Jersey: Prentice Hall, 1996.
32. Lee TE. Statistical methods for survival data analysis. 2nd ed. New York: John Wiley & Sons, 1992.
33. Breslow NE, Day NE. Statistical methods in cancer research. Volume II - The design and analysis of cohort studies. IARC Sci Publ 1987;1-406.
34. Preston DL, Lubin JH, Pierce DA. EPICURE: risk regression and data analysis software. Seattle: HiroSoft International Corporation, 1990.
35. Usuki K, Saras J, Waltenberger J, Miyazono K, Pierce G, Thomason A, et al. Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem Biophys Res Commun 1992;184:1311-6.
36. Moghaddam A, Bicknell R. Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry 1992;31:12141-6.
37. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H, Tominaga T. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer 1995;14:79-82.
38. Nagy JA, Brown LF, Senger DR, Lanir N, Van de Water L, Dvorak AM, et al. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 1989;948:305-26.
39. Liotta LA, Saidel G, Kleinerman J. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 1976;36:889-94.
40. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
41. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecular antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340:1120-4.
42. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 1995;55:510-3.